S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +0.31%
Nvidia 221.97 +2.25%
Microsoft 532.95 −0.11%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7120 +0.15%
CLOSED · 20:15 ET
Market ClerkRecap
Wed Oct 21 · markets closed2 signals today78 insider buys this week · $240.8MCIRO short report next: Oct 31The week ahead
KL
INSIDER · RVMD · Revolution Medicines, Inc. · DIRECTOR

Kim Lorence H.

Every open-market transaction filed under this name, Aug 31 to Sep 8.

Filings
14
0 buys · 14 sells
Bought
—
open market, at cost
Sold
$15M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 8RVMDRevolution Medicines, Inc.DirectorSell371$212.27$79K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell3,844$211.36$812K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell4,730$210.50$996K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell2,853$209.56$598K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell3,587$208.55$748K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell999$207.33$207K—
Sep 8RVMDRevolution Medicines, Inc.DirectorSell706$206.60$146K—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell625$206.15$129K—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell2,128$205.19$437K—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell7,271$204.35$1.5M—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell26,160$203.55$5.3M—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell12,919$202.48$2.6M—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell6,597$201.47$1.3M—
Aug 31RVMDRevolution Medicines, Inc.DirectorSell300$200.56$60K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.